Experimental virus injected into tumors shows early promise, but trial on hold
Disease control
Terminated
This early-stage trial tests a modified herpes virus (BS006) that is injected directly into tumors to kill cancer cells and activate the immune system. It involves 29 adults with advanced solid tumors like melanoma or breast cancer. The study is currently suspended, and its main …
Phase: PHASE1 • Sponsor: Binhui Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC